Atrioventricular dissociation (AVD) is a condition in which the atria and ventricles are activated independently, without the normal conduction of the sinus impulse through the atrioventricular (AV) node. Under physiological conditions, the AV node serves as the link between atrial and ventricular electrical activation, ensuring synchronous contraction of both cardiac chambers. In AVD, this synchronization is lost, leading to potential impairment of cardiac function.
Based on duration, AV dissociation can be categorized into two main types:
Transient: occurs temporarily and resolves spontaneously. It may be observed in scenarios such as non-sustained ventricular tachycardia, pharmacological effects, or interference phenomena in cardiac rhythm.
Persistent: sustained over time, often associated with chronic conduction system dysfunction, such as advanced AV block or accelerated escape rhythms.
The distinction between transient and persistent AVD is clinically significant, as transient forms often require no specific treatment, whereas persistent forms may demand therapeutic intervention.
The prevalence of AVD varies depending on the clinical context and underlying cause. It is not a specific pathological entity but rather a phenomenon that may appear in various cardiac conditions.
Advanced AV blocks: AVD is present in all patients with complete AV block, being a direct consequence of interrupted AV conduction.
Ventricular arrhythmias: common in patients with sustained ventricular tachycardia, where ectopic ventricular rhythm dominates cardiac activation.
Accelerated escape rhythms: accelerated idioventricular rhythm (AIVR) may cause transient AVD, particularly post-myocardial infarction.
Pharmacologic effects: some antiarrhythmic drugs, such as beta-blockers and calcium channel blockers, can induce transient AV dissociation.
Ventricular pacing: AVD may occur in patients with ventricular pacemakers as a consequence of device programming.
AVD is more frequently observed in the elderly and in individuals with structural heart disease, whereas in young and healthy individuals, it is rare and generally transient. Its clinical significance depends on the type and underlying cause, with persistent forms having greater prognostic implications than transient ones.
Etiology, Pathogenesis, and Pathophysiology
Atrioventricular dissociation (AVD) is characterized by the loss of synchronization between atrial and ventricular activity, with independent electrical activation of the two cardiac chambers. This phenomenon may occur in various clinical settings and arises from conduction disturbances, interference from ectopic rhythms, or usurpation by a hyperactive ventricular focus.
🔹 Causes of Atrioventricular Dissociation
Causes of AVD vary depending on the underlying mechanism. Some pathological conditions lead to interrupted AV conduction, while others promote ectopic rhythms that interfere with normal impulse propagation. Major causes include:
Conduction system diseases: degeneration of the AV node, fibrosis of the His-Purkinje system, and post-myocardial infarction sequelae may impair atrioventricular impulse transmission.
Ventricular arrhythmias: sustained ventricular tachycardias may lead to atrial-ventricular rhythm dissociation.
Accelerated escape rhythms: in settings such as accelerated idioventricular rhythm (AIVR) or accelerated junctional rhythm, an ectopic focus may outpace the sinus node and induce AV dissociation.
Pharmacologic effects: agents such as beta-blockers, calcium channel blockers, digoxin, and antiarrhythmic drugs may affect AV conduction and favor AVD onset.
Pacemaker stimulation: in patients with ventricular pacemakers programmed in VVI mode, atrial activity may become dissociated from ventricular rhythm, resulting in iatrogenic AV dissociation.
From a pathophysiological standpoint, AVD can be classified into three main types: AV dissociation due to block, AV dissociation due to interference, and AV dissociation due to usurpation. This classification provides insight into the underlying mechanisms and clinical implications.
🔹 1. AV Dissociation due to Block
This form occurs when conduction through the AV node is completely interrupted, preventing atrial impulses from reaching the ventricles. In the absence of transmission, ventricular activation relies on an escape rhythm originating at the junctional (narrow QRS) or ventricular level (wide QRS).
Main causes of block-related AVD include:
Third-degree AV block: complete interruption of conduction between atria and ventricles.
Degenerative conduction system disease: fibrosis of the AV node or His-Purkinje system.
Myocardial ischemia: inferior infarction involving the AV node.
Infiltrative diseases: sarcoidosis, amyloidosis, and other pathologies that impair impulse transmission.
Pathophysiologically, the atria continue to contract at their own rate, while the ventricles activate independently via an escape pacemaker. Although this maintains some degree of cardiac output, it may be insufficient—especially if the escape rhythm is bradycardic. Loss of atrioventricular synchronization results in ineffective ventricular filling, leading to decreased cardiac output, hypotension, and potentially syncope. In severe cases, permanent pacemaker implantation may be necessary to restore effective conduction.
🔹 2. AV Dissociation due to Interference
This form occurs when an accelerated ectopic rhythm assumes control of ventricular activation, surpassing the sinus node rate and preventing sinus conduction.
Main causes of interference-related AVD include:
Accelerated idioventricular rhythm (AIVR): common in the post-infarction phase.
Accelerated junctional rhythm: hyperactivity of the AV node, frequently post-cardiac surgery.
Digitalis and antiarrhythmic drugs: increase the automaticity of ectopic foci.
Pathophysiologically, the AV node remains intact, but the ventricles are driven by an ectopic focus firing at a rate higher than that of the sinus node. If the ectopic rhythm is stable, cardiac output may remain preserved, and the patient may be asymptomatic. However, if the ectopic rhythm is unstable, with sudden changes in ventricular rate, hypotension, reduced exercise tolerance, dizziness, or near-syncope may occur. In some cases, when the interfering rhythm is fast and persistent, ventricular function may become impaired and require specific treatment.
🔹 3. AV Dissociation due to Usurpation
This form occurs when a ventricular ectopic rhythm accelerates to the point of dominating the entire cardiac activation, rendering atrial conduction ineffective.
Main causes of usurpation-related AVD include:
Sustained ventricular tachycardia: typical of accelerated ventricular arrhythmias.
Ventricular pacing: in VVI pacemaker modes, ventricular activation occurs independently of atrial activity.
From a physiological perspective, the ventricular rhythm becomes entirely independent of atrial rhythm, disrupting atrial-ventricular contraction coordination. When ventricular rates are high, diastolic filling time shortens, causing hypotension and reduced peripheral perfusion. In critical cases, electrical cardioversion may be required to restore atrioventricular synchrony and stabilize the patient's hemodynamics.
Clinical Presentation
Clinical manifestations of atrioventricular dissociation (AVD) depend on the type of dissociation, ventricular rate, and the cardiovascular system’s ability to compensate for lost atrioventricular synchrony. In milder forms, AVD may be asymptomatic and discovered incidentally, while in severe forms it may cause symptoms due to reduced cardiac output and inefficient ventricular filling.
🔹 Symptoms
Symptoms vary based on the severity of the dissociation. Common clinical features include:
Fatigue and weakness: caused by decreased peripheral perfusion due to loss of atrioventricular synchrony.
Dyspnea: may occur at rest or during exertion, especially in patients with underlying heart failure.
Dizziness or near-syncope: linked to decreased cardiac output, particularly with marked bradycardia.
Syncope: observed in severe cases, especially in block-related AVD with very low ventricular rates.
Palpitations: some patients may perceive irregular heartbeats due to the lack of coordination between atrial and ventricular contractions.
🔹 Clinical Signs
On physical examination, the pulse may be irregular or bradycardic, with a ventricular rate slower than the atrial rate. In some patients, the "cannon A waves" sign may be observed—prominent jugular venous pulsations due to atrial contraction against a closed AV valve. Blood pressure may be reduced, with possible episodes of orthostatic hypotension. In patients with persistent AVD and hemodynamic compromise, signs of heart failure may be present, such as jugular venous distension and peripheral edema.
Diagnosis
The diagnosis of atrioventricular dissociation (AVD) relies on clinical evaluation and electrocardiography (ECG), which is the key tool for confirming the dissociation between atrial and ventricular activation. In uncertain or intermittent cases, prolonged monitoring or electrophysiological testing may be required to better characterize the disorder.
🔹 Electrocardiogram (ECG): Diagnostic Criteria
ECG confirms AVD when three fundamental criteria are present:
P waves dissociated from QRS complexes: P waves have their own rhythm and no fixed relationship with QRS, indicating independent atrial and ventricular activity.
Atrial and ventricular rates differ: each rhythm proceeds at a different rate with no fixed association between P waves and QRS complexes.
Absence of consistent retrograde conduction: in ectopic ventricular rhythms, retrograde conduction may sporadically activate the atria, but in true AVD, it is irregular or absent.
Once AVD is confirmed, ECG helps differentiate among the various forms based on the type of ventricular rhythm and the relationship between P waves and QRS complexes.
🔹 Electrophysiological Classification
AVD can be electrophysiologically categorized into three main types:
✅ AVD due to Block
Occurs when AV conduction is completely interrupted, and ventricles are driven by an escape rhythm.
Regular P waves, independent from QRS complexes.
Escape rhythm: with narrow QRS if junctional, wide QRS if ventricular.
Regular R-R intervals, as the escape rhythm is autonomous.
P waves may occasionally appear near QRS complexes but without altering their morphology.
✅ AVD due to Interference
This form arises from an accelerated ectopic rhythm outpacing the sinus node, preventing normal conduction.
Regular QRS complexes, more frequent than P waves.
Dissociated P waves, superimposed on QRS or visible between ventricular complexes.
No AV block: the AV node is intact, but conduction is masked by the faster ectopic rhythm.
✅ AVD due to Usurpation
An ectopic ventricular focus accelerates enough to dominate the entire rhythm, suppressing sinus activity.
Ventricular rate faster than atrial, with complete suppression of sinus rhythm.
Wide, irregular QRS complexes, typical of accelerated ventricular rhythms.
No relationship between P waves and QRS, with full dominance of the ectopic rhythm.
🔹 Prolonged Monitoring
If AVD is intermittent or not captured on a standard ECG, prolonged monitoring may be required to correlate symptoms with rhythm disturbances. Commonly used methods include:
24–48-hour Holter ECG: useful to document transient AVD episodes and their duration.
Implantable ECG monitor: indicated in patients with unexplained syncope and suspected paroxysmal AVD.
Exercise testing: assesses chronotropic response in patients with intermittent AVD.
🔹 Electrophysiological Study
The intracardiac electrophysiological study may be indicated in patients with suspected AVD when non-invasive tests are inconclusive. This examination assesses AV nodal function, identifies infra-Hisian blocks, and helps determine the indication for pacemaker implantation in symptomatic patients.
Treatment
Treatment of atrioventricular dissociation (AVD) depends on the underlying cause, the severity of the clinical presentation, and the presence of symptoms. In some transient or asymptomatic forms, no specific intervention is required. However, in persistent and symptomatic forms, management should focus on correcting the cause, stabilizing the patient, and, in severe cases, considering pacemaker implantation.
🔹 Elimination of Reversible Causes
When AVD is secondary to modifiable factors, priority should be given to addressing the precipitating cause. This may include:
Withdrawal of bradycardic drugs: beta-blockers, non-dihydropyridine calcium channel blockers, digoxin, and antiarrhythmic agents should be tapered or discontinued if contributing to AV dissociation.
Treatment of myocardial ischemia: in AVD associated with myocardial infarction, revascularization may restore AV conduction.
Correction of electrolyte imbalances: hyperkalemia, hypocalcemia, and hypomagnesemia may impair AV conduction and should be promptly corrected.
Management of infiltrative diseases: targeted treatment of sarcoidosis, amyloidosis, or similar conditions may improve AV conduction.
🔹 Pharmacological Therapy
In symptomatic AVD, medications can help stabilize heart rate and support AV conduction:
Atropine: useful acutely to increase heart rate in AVD with symptomatic bradycardia.
Beta-adrenergic agonists (e.g., isoproterenol, low-dose dopamine): indicated in severe bradycardia while awaiting permanent pacemaker implantation.
Steroids and immunosuppressants: may improve conduction in AVD secondary to autoimmune or infiltrative myocarditis.
🔹 Pacemaker Implantation
For persistent and symptomatic AV dissociation, pacemaker implantation is the definitive treatment. The choice of device depends on the AVD type and patient characteristics:
Dual-chamber pacemaker (DDD): indicated in complete AV block to ensure atrioventricular synchrony.
Single-chamber ventricular pacemaker (VVI): used in patients with AVD and permanent atrial fibrillation.
Physiologic conduction system pacing: in selected patients, direct stimulation of the His bundle or left bundle branch may offer an advanced alternative.
Prognosis
The prognosis of AVD varies according to the underlying cause and treatment response. Transient forms, often due to drugs or metabolic imbalances, generally have a favorable prognosis once the trigger is removed. Persistent forms may pose significant risks of hemodynamic instability, syncope, and heart failure.
In patients treated with pacemakers, quality of life improves significantly, and the risk of adverse events is reduced. However, regular follow-up is essential to monitor device function and disease progression.
Complications
Major complications of AVD stem from impaired atrioventricular synchrony and potential hemodynamic deterioration. The most frequent complications include:
Syncope and falls: in elderly patients, syncopal episodes increase the risk of trauma and fractures.
Heart failure: reduced cardiac output in symptomatic AVD may contribute to heart failure development.
Ventricular fibrillation: in severe cases, AVD may predispose to life-threatening ventricular arrhythmias.
Pacemaker syndrome: in patients with non-physiologic ventricular pacing, disrupted ventricular filling may worsen cardiac performance.
Early recognition of AVD and optimal management of underlying causes are essential to prevent complications and ensure appropriate treatment for affected patients.
References
Zipes DP, Libby P, Bonow RO, Mann DL, Tomaselli GF. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 11th ed. Elsevier; 2019.
Brugada J, Katritsis DG, Arbelo E, et al. 2019 ESC Guidelines for the management of patients with supraventricular tachycardia. Eur Heart J. 2020;41(5):655-720.
Barold SS, Ilercil A. Electrocardiographic patterns of atrioventricular dissociation. Cardiol J. 2016;23(2):139-147.
Rosen MR, Edvardsson N, Bergfeldt L. Atrioventricular dissociation: Mechanisms and clinical significance. Circ Arrhythm Electrophysiol. 2020;13(5):e008292.
Mangi MA, Aziz W, Das JM. Atrioventricular Dissociation. StatPearls [Internet]. StatPearls Publishing; 2023.
Gula LJ, Skanes AC, Klein GJ, et al. Clinical significance and management of AV dissociation. J Cardiovasc Electrophysiol. 2018;29(11):1505-1513.
Wellens HJ, Schwartz PJ, Lindemans FW. Recognition and management of AV dissociation in patients with pacemakers. J Am Coll Cardiol. 2021;78(3):274-286.
Alboni P, Brignole M, Menozzi C, et al. Long-term outcome of patients with AV dissociation and bradyarrhythmias. Pacing Clin Electrophysiol. 2019;42(4):469-476.
